Czech scientists in the fight against coronavirus
11. 02. 2020
Czech scientists participated in the development of a new test confirming the presence of coronavirus 2019-nCoV in the body. The company TATAA Biocenter (Göteborg, Sweden) in cooperation with the laboratory of prof. M. Kubista from the Institute of Biotechnology of the Czech Academy of Sciences and Saint James Hospital Malta) has developed a new diagnostic kit. The Red Cross has expressed interest in its use in China.
The first patient samples are being tested at Saint James Hospital, Malta.
Coronavirus 2019-nCoV belongs to the family of Coronaviridae, which causes respiratory diseases in animals and humans. The viruses in this family bring about common problems such as colds, coughs, breathing difficulties, and fevers. But they are also the cause of the deadly Severe Acute Respiratory Syndrome (SARS) and MERS (Middle East Respiratory Syndrome).
Three months have passed since the first confirmed occurrence of the new type of coronavirus 2019nCoV in Wuhan, China, and it is still spreading. According to the World Health Organization, more then 20 thousand cases and four hundred deaths have been confirmed worldwide.
Prepared by: Kateřina Sedláčková, Institute of Biotechnology CAS
- The Human Brain Project 2020 Open Day
- Social anthropologist Luděk Brož has received a prestigious ERC grant
- Self-assembly of the cytoskeleton can be influenced by electrical pulses
- The Fascinating Story about Suppressing HIV
- ALLEA's Call for a Strong Programme
- Towards the ESFRI Roadmap 2021 – a new ambition for European science
- Nanodiamonds help decompose nerve agents
- The CAS signed an agreement with a research centre of the European Union
- CEVAST is a new hope for technology ethics, says Forbes magazine
- Czech scientists helped to “read” the genome of pea